These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 8443455

  • 1. [Plasminogen activator and PAI. Detection in aqueous humor of the human eye].
    Steinkamp GW, Hattenbach LO, Heider HW, Scharrer I.
    Ophthalmologe; 1993 Feb; 90(1):73-5. PubMed ID: 8443455
    [Abstract] [Full Text] [Related]

  • 2. [Tissue plasminogen activator and plasminogen activator inhibitor in aqueous humor].
    Giedrojć J, Stankiewicz A, Walkowiak M, Galar M, Bielawiec M.
    Klin Oczna; 1996 Feb; 98(4):283-5. PubMed ID: 9463119
    [Abstract] [Full Text] [Related]

  • 3. [Tissue plasminogen activator (t-PA) in aqueous humor of patients with cataract].
    Kotschy M, Kałuzny J, Kaniasty M, Zekanowska E, Kropińska E.
    Klin Oczna; 1996 Mar; 98(3):201-3. PubMed ID: 9019589
    [Abstract] [Full Text] [Related]

  • 4. Increased basal levels of free plasminogen activator activity found in human aqueous humor.
    Wang Y, Taylor DM, Smalley DM, Cone RE, O'Rourke J.
    Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3561-6. PubMed ID: 8056534
    [Abstract] [Full Text] [Related]

  • 5. Tissue plasminogen activator activity in human aqueous humor.
    Smalley DM, Fitzgerald JE, Taylor DM, Cone RE, O'Rourke J.
    Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):48-53. PubMed ID: 8300363
    [Abstract] [Full Text] [Related]

  • 6. Plasminogen activators and plasminogen activator inhibitors in gingival crevicular fluid of cyclosporin A-treated patients.
    Buduneli N, Buduneli E, Ciotanar S, Atilla G, Lappin D, Kinane D.
    J Clin Periodontol; 2004 Jul; 31(7):556-61. PubMed ID: 15191592
    [Abstract] [Full Text] [Related]

  • 7. [The correlation study of the expression of VEGF with t-PA and PAI expression in plasma and intraocular tissue in proliferative diabetic retinopathy].
    Wu S, He X.
    Zhonghua Yan Ke Za Zhi; 2014 Jun; 50(6):448-53. PubMed ID: 25241978
    [Abstract] [Full Text] [Related]

  • 8. Fibrinolytic activity and localization of plasminogen activator in bovine vitreous body and aqueous humor.
    Hayashi K, Nakashima Y, Sueishi K, Tanaka K.
    Jpn J Ophthalmol; 1989 Jun; 33(1):66-75. PubMed ID: 2499726
    [Abstract] [Full Text] [Related]

  • 9. [Quantification of a specific inhibitor (PAI-1) of tissue-type plasminogen activator (t-PA) in the plasma].
    Masson C, Angles-Cano E.
    Ann Biol Clin (Paris); 1989 Jun; 47(5):269-74. PubMed ID: 2500878
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
    Wojta J, Turcu L, Wagner OF, Korninger C, Binder BR.
    J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431
    [Abstract] [Full Text] [Related]

  • 11. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D, Kremplewska-Nalezyta E, Gadomska G, Zastawna E, Michalski A, Drewniak W.
    Med Sci Monit; 2000 Jun; 6(4):684-91. PubMed ID: 11208392
    [Abstract] [Full Text] [Related]

  • 12. Urokinase-type plasminogen activator in human aqueous humor.
    Bernatchez SF, Tabatabay C, Belin D.
    Invest Ophthalmol Vis Sci; 1992 Aug; 33(9):2687-92. PubMed ID: 1639615
    [Abstract] [Full Text] [Related]

  • 13. Plasminogen activator system in oral squamous cell carcinoma.
    Baker EA, Leaper DJ, Hayter JP, Dickenson AJ.
    Br J Oral Maxillofac Surg; 2007 Dec; 45(8):623-7. PubMed ID: 17590247
    [Abstract] [Full Text] [Related]

  • 14. [Problems in measuring parameters of the fibrinolytic system: circadian rhythm of tissue-type plasminogen activator and plasminogen activator inhibitor].
    Köhler M, Miyashita C.
    Klin Wochenschr; 1988 Dec; 66 Suppl 12():62-7. PubMed ID: 3126347
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic impact of urokinase-type plasminogen activator (PA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: a prospective study on multicenter basis.
    Kim SJ, Shiba E, Kobayashi T, Yayoi E, Furukawa J, Takatsuka Y, Shin E, Koyama H, Inaji H, Takai S.
    Clin Cancer Res; 1998 Jan; 4(1):177-82. PubMed ID: 9516968
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tissue plasminogen activator (t-PA) and placental plasminogen activator inhibitor (PAI-2) in gingival crevicular fluid from patients with Papillon-Lefèvre syndrome.
    Ullbro C, Kinnby B, Lindberg P, Matsson L.
    J Clin Periodontol; 2004 Sep; 31(9):708-12. PubMed ID: 15312091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.